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Sunday, March 1, 2009 105aIn MDCK cells, Slo1 channels are mainly expressed at the apical surface. Sim-
ilarly, transiently transfected MDCK cells target Slo1 channels to their apical
surface. To study the role of the microtubules on apical localization of Slo1
channels, we used a viral construct of Slo1 attached to EGFP (Slo1-EGFP)
to induce the expression of Slo1. After 72 hrs of infection, cells were either
treated with vehicle (control) or with 33 mM nocodazole to disrupt the micro-
tubules. Cells were fixed and immunolabeled with anti a-tubulin to visualize
the microtubule network. Using high-resolution confocal microscopy, we
found that in control cells the microtubules are localized towards the apical sur-
face, as Slo1. After nocodazole treatment, the microtubule network is com-
pletely disrupted and Slo1-EGFP is observed in both apical and basolateral sur-
faces. To further understand the mechanisms of Slo1 targeting in MDCK cells,
we blocked protein synthesis with 1 mg/ml cycloheximide simultaneously with
microtubule disruption. In these cells, Slo1-EGFP expression, although still lo-
calized at both surfaces, was less prominent at the basolateral surface than with-
out cycloheximide. This result indicates that a part of Slo1-EGFP localized at
the basolateral surface after microtubule disruption is redirected from the apical
surface and a part of these proteins are newly synthesized. Thus, our results
show that in MDCK cells the microtubule network plays an important role in
Slo1 apical localization and that normal Slo1 traffic is likely transcytotic first
reaching the basolateral surface, then traveling to the apical surface via the mi-
crotubule network. Supported by NIH.
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Familial mutations in hERG, the Human Ether-a-go-go Related Gene, disrupt
cardiac IKr, leading to Type 2 Long QT Syndrome and potentially fatal ventric-
ular arrhythmias. Of the more than 200 mutations identified to date, eight are
nonsense mutations in the hERG 1a amino terminus (NT). How these muta-
tions cause disease is unknown. We found that constructs corresponding to
six of these LQT2-linked mutations encoded stable, truncated NT fragments
when expressed in HEK cells. We coexpressed these fragments with WT
hERG 1a and 1b subunits to mimic heterozygous expression in LQT2 patients
and assessed their effects on WT hERG trafficking and expression levels.
Western blots revealed that the polypeptides significantly decreased WT 1a
and 1b protein expression levels. We hypothesized N-N terminal interactions
may mediate the observed reduction and indeed found levels of N-deleted
hERG 1a subunit (N-del) were unaffected by the LQT2 polypeptides. Surpris-
ingly, the LQT2 fragments promoted 1a N-del maturation. This indicates the
polypeptides are not inherently misfolded and can rescue 1a N-del trafficking,
possibly by interacting with downstream regions of the subunit. Reduction of
WT protein levels by LQT2 polypeptides therefore requires an intact N-termi-
nus. To determine if the LQT2 polypeptides destabilize WT subunits, we
blocked protein synthesis using cycloheximide and tracked WT protein levels
over time. Co-expression with LQT2 polypeptides caused a rapid loss of both
immature and mature hERG 1a and 1b compared with control indicating accel-
erated degradation in the ER. In summary, this study demonstrates a novel dis-
ease mechanism in which LQT2-linked nonsense mutations in the hERG 1a
N-terminus act in a dominant-negative manner by destabilizing ER-resident
WT subunits.
Support: HL081780 (GAR) and AHA predoctoral fellowship and
T32HL007936 (ECRR).
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The KCNH2 or human ether-a-go-go related gene (hERG1) encodes the
Kv11.1 a-subunit of the hERG potassium channel that underlies the rapidly ac-
tivating delayed rectifier current IKr. In the heart, mutations in KCNH2 cause
a reduction in IKr resulting in the proarrhythmic type 2 long-QT syndrome
(LQT2). While multiple factors can cause the loss of the functional phenotype,
the dominant mechanism is a trafficking deficiency due to abnormalities in pro-
tein folding that result in endoplasmic reticulum (ER) retention. To identify
chaperones or co-chaperones potentially involved in the folding and ER reten-
tion of hERG we performed a proteomics analysis to identify hERG-interact-
ing proteins. In addition to Hsc70 and Hsp90, key members of the cytosolic
chaperone system, we found the co-chaperones Dja1, Bag2, Hop, Tpr2,
FKBP38, and the lumenal chaperone calnexin. We recently reported on the pu-
tative ER-resident hERG chaperone FKBP38. FKBP38 co-precipitates with
hERG both in vivo and in vitro. Functionally, siRNA knockdown of
FKBP38 reduces wild type (WT) hERG trafficking. In vitro experimentshave also confirmed that translated hERG C-terminus (CT) and cyclic nucleo-
tide binding domain (CNBD) bind to Hsc70 and Hsp90 as well as Dja1 and
related family members Dja2 and Dja4. In vivo results indicate that overex-
pression of the Dja proteins result in differential reduction of hERG trafficking.
This reduction in hERG trafficking appears to be related to the proteasomal
degradation system as inhibiting the proteasome with lactacystin diminishes
this effect and re-establishes hERG trafficking to control levels. Another pro-
tein involved in degradation, Chip, was also tested and preliminary work indi-
cates that its overexpression leads to decreased hERG expression. Taken to-
gether, these data allow us to outline a model of chaperone-mediated hERG
maturation and quality control.
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Nicotine addiction is the world’s leading preventable cause of mortality.
Smokers also have a much lower incidence of Parkinson’s disease. A plausible
cellular/molecular mechanism for some responses to chronic nicotine is
selective chaperoning of acetylcholine receptor number and stoichiometry
(S-CHARNS). To investigate S-CHARNS in a neuronlike environment, we
are using single-molecule fluorescence microscopy to monitor localization
and trafficking of a4(eGFP)b2 and a4(eGFP)b4 nAChRs expressed in neuro-
blastoma cells (N2a). As in previous investigations on native neurons and
heterologous expression systems, we find large pool(s) of intracellular
a4(eGFP)b2 receptors predominantly localized in the endoplasmic reticulum
(ER). We also find a4(eGFP)* receptors on vesicles (mobile puncta with dif-
fraction-limited profiles consistent with the point-spread function of our micro-
scope). Time-lapse photobleaching analyses of docked or fused vesicles indi-
cate that vesicles carry 1-2 a4(eGFP)b2 receptor(s). In contrast, cells
expressing a4(eGFP)b4 display (a) fewer ER-localized a4(eGFP)* receptors,
(b) 5-fold more a4(eGFP)* receptors/vesicle, and (c) ~10-fold more receptors
at the plasma membrane (perhaps resulting from (a) and (b)). The b2 and b4
subunits differ most in the M3-M4 intracellular loop, which includes several
motifs that may govern the distinct roles of b2 and b4 subunits in a4* receptors.
Chronic exposure (24-48 h) to 0.1 mMnicotine results in increased a4(eGFP)b2
or a4(eGFP)b4 receptors at the plasma membrane. We observe many more
a4(eGFP)b2 receptors in the filopodia in nicotine-treated cells compared to
non-nicotine treated control cells. Thus high-resolution, quantitative imaging
of S-CHARNS is providing data required to understand, and eventually to
manipulate, changes due to chronic nicotine exposure.
R.P. and R.S. contributed equally to this work. Grants: NS11756, DA17279,
Michael J. Fox, Philip Morris, Targacept. Fellowships: Ford and APA-DPN
(RP). AHA postdoctoral (FJM).
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Pancreatic ATP sensitive potassium (KATP) channels play an important role in
insulin secretion, linking the metabolic state of the beta cell to its excitability.
Protein kinase C (PKC) has previously been shown to down regulate the cell
surface density of KATP channels in cardiac, neuronal and recombinant cells,
but there are no studies on pancreatic beta cells. Here we show that activation
of PKC results in significant down regulation of KATP channel conductance in
the model beta cell line, INS1e. To investigate the underlying mechanism, we
expressed a Kir6.2 construct containing an extracellular HA epitope plus SUR1
in INS1e and HEK293 cells and examined the role of PKC in regulation of cell
surface density and endosomal trafficking. We found that PKC activation with
the phorbol ester drug PMA reduced the surface density of KATP channels by
reducing recycling of endocytosed channels, but had no effect on the rate of en-
docytosis. Endocytosed channels entered the peripheral and perinuclear com-
partments when PKC was activated, but remained at a peripheral location
when PKCwas inhibited with chelerythrine. Since pancreatic beta-cells express
9 different isoforms of PKC, we asked which of these isoforms is responsible
for the observed effect. Using the dominant negative approach, our results show
that PKC epsilon regulates endosomal trafficking of KATP channels. We con-
clude that that activation of PKC epsilon leads to dramatic changes in the dis-
tribution of internalised KATP channels and that the decrease in channel surface
density is due to inhibition of channel recycling. The results may have impor-
tant consequences for the electrical excitability of the pancreatic beta cell and
therefore the insulin secretory response.
